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ABSTRACT
Despite being a known toxin for several centuries, lead (Pb2+) is still utilized in 
commercial products including leaded gasoline, paint, and modern cosmetics. 
This presence has caused Pb2+ to pollute the environment, including public 
drinking water sources. The recent outbreaks of elevated levels of Pb2+ in the 
drinking water in Flint, Michigan and Washington D.C. have caused large 
populations to be exposed to the heavy metal for months at a time, raising a 
public health concern over the implications of widespread, long-term Pb2+ 
exposure. Young children are most susceptible to the effects of Pb2+ toxicity, 
exhibiting symptoms of cognitive and behavioral impairments. These symptoms 
are closely related to those exhibited by autism spectrum disorder (ASD) 
patients. ASD is of unknown etiology but is thought to be caused by a mixture of 
genetic factors and environmental toxins. ASD is also linked to abnormal 
serotonin functionality due to a large population being treated with selective 
serotonin reuptake inhibitors (SSRIs) to decrease anxiolytic behaviors. Serotonin 
(5-HT) is a neurotransmitter heavily involved in development, mood, and sleep. 
Despite the connection between ASD-like symptoms and Pb2+ exposure, there 
have been no studies chronicling the effects of Pb2+ exposure on the 
serotonergic system in vivo. We hypothesize that serotonergic neurotransmission 
will be altered as a direct result of Pb exposure. In vivo measurements require 
high temporal resolution, selectivity, and sensitivity; all achieved with fast-scan 
vi 
cyclic voltammetry (FSCV) and microelectrodes. Due to Pb2+ exposure greatly 
affecting and serotonin’s critical role in proper development, the medial prefrontal 
cortex (mPFC) was chosen due to its dense population of serotonin neurons as 
well as being the last region to fully develop. In this study, mature mice were 
exposed to Pb2+ in three experimental paradigms: acute, chronic, and perinatal 
studies. Behavioral tests were performed on the perinatal cohort prior to 
voltammetric measurements to observe any behavioral alterations as a result of 
Pb consumption. It was found that Pb2+ affected the amplitude, but not the 
reuptake of evoked 5-HT in the acute cohort. There were no significant changes 
in voltammetric measurements nor behaviors after chronic and perinatal 
exposures. This work has shown that acute Pb2+ exposure does alter 
serotonergic neurotransmission in the mPFC, but symptoms were not observed 
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A BEHAVIORAL AND VOLTAMMETRIC STUDY OF THE EFFECTS 




1.1 Introduction  
Lead (Pb2+) has been a well-documented toxin since the 2nd century B.C. 
but has been heavily present in commercial products such as leaded gasoline 
and paint up until the mid-20th century and is currently present in modern 
cosmetics1, 2. Its commercial use has polluted topsoil and drinking water sources 
with Pb2+3. Recently, several public water systems have struggled to keep Pb2+ 
levels in drinking water at the 15-ppb limit set forth by the Environmental 
Protection Agency (EPA), most notably: Flint, Michigan and Washington D.C4, 5. 
These large populations have been chronically exposed to Pb2+ at elevated 
levels for months at a time. As a result, these outbreaks have raised public health 
concern for the short and long-term health effects of Pb2+ exposure. 
The effects of Pb2+ on the body are well-known2. Pb2+ can mimic Fe2+ in 
red blood cells, causing anemia6. This can subside with the administration of a 
chelating agent, but not completely. When chronically consumed, Pb2+ gets 
stored in bones and teeth, which can leech into the bloodstream over time, 
prolonging the effects of Pb2+ exposure after treatment. Additionally, Pb2+ readily 




mimic and compete with Ca2+ during action potentials, disrupting 
neurotransmission8. It has been shown that this phenomenon can increase 
normal firing of neurotransmitters and decrease evoked signals9. Altering 
homeostatic neurotransmission can lead to unknown, downstream effects that 
could manifest as observed behavioral changes.  
There is ample evidence that developing brains are more susceptible to 
the effects of Pb2+ exposure than adults10-12. Before the age of seven, synapses 
and learning pathways are forged in the brain and disrupting this process causes 
prolonged long-term effects13. Children exposed to Pb2+ suffer from cognitive and 
behavioral deficits including altered social skills, aggressive behaviors, 
hyperactivity, and low IQ’s. These behaviors are like those exhibited by patients 
with autism spectrum disorder (ASD), forging a possible connection. ASD is of 
unknown etiology but is thought to be caused by a combination of genetic factors 
and environmental toxicity14. ASD is characterized by social and learning 
impairments and developmental delays. A concrete connection was made 
between the presentation of ASD behaviors and Pb2+ exposure by Yassa et al., 
where children diagnosed with ASD and elevated blood Pb2+ levels were 
administered a chelating agent15. This treatment resulted in significant decreases 
in blood Pb2+ levels as well as ASD behaviors. A large population of ASD 
patients exhibit anxiolytic behaviors, which are efficaciously treated by selective 
serotonin reuptake inhibitors (SSRIs)16. Serotonin (5-HT) is a neuromodulator 
responsible for regulating sleep and mood, amongst others, but is mostly known 




Additionally, approximately 30% of ASD patients exhibit elevated blood serotonin 
levels, further implicating the neurotransmitter in ASD18. The connection between 
ASD and Pb2+ exposure is clear, however there have been no studies regarding 
serotonergic disruptions. Therefore, we hypothesize that serotonergic 
neurotransmission is disrupted as a result of Pb2+ exposure.  
 The common cognitive and behavioral symptoms of Pb2+ exposure and 
ASD indicates the possibility of serotonergic neurotransmission is altered as a 
result of Pb2+ exposure. Pb2+ causes an inflammatory response, resulting in 
neuroinflammation. Samaranayake et al. has shown that neuroinflammation 
increases histamine levels in the brain while concurrently suppressing serotonin 
levels19, 20. There is currently no literature describing alterations to serotonin 
neurotransmission in vivo, but an in vitro study has shown that Pb2+ has a high 
affinity to bind to the 5-HT2A autoreceptor21. 5-HT2A controls the overall level of 
serotonin in the synaptic space and is associated with learning and memory 
functions in the mPFC22. Additionally, the mPFC is one of the last brain regions 
to fully develop and is densely populated with serotonin neurons, making it the 
ideal region to observe the effects of Pb2+ exposure in terms of developmental 
disruptions13. Since neurotransmission occurs on a sub-second time scale, a 
method to observe discrete changes as a result of Pb2+ exposure must have high 
temporal resolution. Additionally, in vivo methods require selectivity and 
sensitivity in a complex matrix. One such method, fast scan cyclic voltammetry 




microelectrodes. In this study, FSCV will be used to observe changes in 
serotonin neurochemistry in the mPFC as a result of Pb2+ exposure.  
It is important to note that West et al. has previously determined that there 
are two types of serotonin neurons that project to the mPFC23. The two types of 
serotonin neurons are distinguished by the types of transporters expressed to 
take up 5-HT from the synapse. The first type expresses dopamine, 
norepinephrine, and organic cation transporters (DATs, NETs, and OCTs, 
respectively), henceforth referred to as “non-SERTs”.  These transporters take 
up 5-HT non-specifically, therefore quickly, resulting in a single reuptake event, 
shown in figure 1A. The second population of serotonin neurons express 
serotonin transporters (SERTs). SERTs have a high affinity for serotonin, 
therefore they reuptake 5-HT slower than the non-SERTs. The first population of 
serotonin neurons are heavily present throughout all layers of the mPFC, but the 
second population are more densely populated in layers 5-6, shown in figure 1C. 
Both populations of serotonin neurons being present in layers 5-6 and taking up 
serotonin at two different rates results in a double peak, shown in figure 1B, 
where the first reuptake is due to the non-SERTs and the second reuptake by 
SERTs. This information is important in studies, like this, that report FSCV 





Figure 1.1 Serotonergic Projections to the mPFC: this figure is a 
representation of the two types of serotonergic neurons projecting into the 
different layers of the mPFC, reported by West et al. 23. 
 
Overall, this study aims to determine the effects of Pb2+ exposure on the 
serotonergic system in the mPFC in vivo. An acute exposure paradigm was 
employed in mature mice to determine short-term effects on serotonin 
neurotransmission in real-time. Long-term Pb2+ exposures were mimicked with 
one-week chronic and perinatal exposures to determine the effects on both 
behavior and serotonin neurochemistry.  
1.2 Methodology 
1.2.1 Study Design 
The Guide for the Care and Use of Laboratory Animals, as accepted by the 
Institutional Animal Care and Use Committees of the University of South Carolina 
(Institution Approval # A3049-01), was followed in all animal care and 




Laboratories (Bar Harbor, ME) at 6 weeks old. Mice were group housed on a 12-
hour light/dark cycle at the University of South Carolina and had access to food 
and water ad libitum. Three separate exposure paradigms: acute, chronic, and 
perinatal to Pb2+ were followed. For the acute exposure, mice were chosen at 
random between 7-10 weeks old, with no regard for the estrous cycle of female 
mice. These mice underwent stereotaxic surgery and FSCV was utilized to 
examine serotonin neurochemistry. After control files of evoked 5-HT were taken, 
animals were given an injection of 1.5, 15, or 150 ppb lead acetate in saline (5 
mL/kg) (Sigma Aldrich) intraperitoneally. Serotonin neurochemistry was observed 
for 60 minutes after the acute injection. The chronic cohort of mice were exposed 
to either normal water from the animal care center, filtered with a reverse 
osmosis filter, or water from the animal care center containing 15 ppb lead 
acetate (Sigma Aldrich). These mice were exposed to Pb2+ for 7 days total, then 
were given Pb2+-free water to drink and stereotaxic surgeries were performed 
within a week. As for the perinatal cohort of mice, two adult breeders were 
housed together with drinking water containing 15 ppb Pb2+ acetate, as 
previously described. They were exposed to this drinking water until their pups 
were weaned into groups at 21 days old. Both the breeders and pups were then 
given normal drinking water from the animal care center. Behavioral tests were 
administered to the pups at 8 weeks old and stereotaxic surgeries followed within 




1.2.1.1 Behavioral Tests  
 
The three-chamber sociability, marble burying, and olfactory 
habituation/dishabituation tests were chosen to examine whether the mice 
perinatally exposed to Pb2+ exhibited ASD-like behaviors. The elevated zero 
maze test was performed to determine additional anxiety caused by the other 
tests. 
1.2.1.2 Three-Chamber Sociability Test 
A custom built three chamber apparatus was utilized with dimensions 
according to commercially available equivalents from Ugo Basile. The cage cups 
used were purchased from Ugo Basile. The perinatal and chronic cohorts were 
given this test. Each mouse was chosen at random to be the test subject for each 
trial. In a three-chamber enclosure, the mouse was restricted to the center 
chamber to habituate for 5 minutes, then allowed to roam in any chamber for 10 
minutes. After which, a familiar or novel mouse was put into a cage cup in either 
the left or the right chamber, which alternated with each test subject. The test 
subject could roam with the doors open for 10 minutes with a familiar mouse and 
10 minutes with a novel mouse.  
1.2.1.3 Olfactory Habituation/Dishabituation 
For the olfactory habituation/dishabituation test, the mice were singly housed 
without food or water for the 45-minute habituation period and the test itself. The 
mice were exposed to 5 scents: 18.2 MΩ Millipore water, two non-social odors, 
almond and orange extract, and two social odors. The non-social odor solutions 




and was repeated for the orange extract solution. When preparing the cotton 
swabs for testing, three swabs were prepared for each odor per mouse. Each 
swab received 50 μL of odorant and was stored in an Erlenmeyer flask and 
covered with parafilm. The social odors were prepared by swabbing the bottom 
of two cages of mice of the same sex, which hadn’t been cleaned for a minimum 
of two days. The mice were exposed to each odor for two minutes and 
dishabituated for one minute. This was repeated three times per odor beginning 
with water, then the non-social odors, finishing with the social odors. Noldus 
Ethovision was used to record and score the time spent sniffing the novel and 
familiar mice. A t-test was performed to determine the statistical significance of 
time spent with the novel vs. familiar mouse as well as time sniffing the mouse in 
the chamber cage vs. being away from it.  
1.2.1.4 Marble Burying Test 
For the marble burying test, biofresh comfort bedding was used because the 
cellulose fibers promote burying. Each mouse was singly housed without water 
or food access for the duration of the habitation and test. A ten-minute 
habituation period was allowed prior to the introduction of 12 marbles. The 
marbles were placed in a grid pattern while the mouse was temporarily removed 
from the cage. The mice were returned to the cage with marbles in it for a ten-
minute test. After which, the marbles were scored as buried, partially buried, or 
not buried. Partially buried marbles were determined as visible but had bedding 




each mouse. The two cohorts were averaged, and the groups were compared 
with a t-test.  
1.2.1.5 Observation of Repetitive Behaviors  
Mice were singly housed during this test without access to food or water. 
They were given a fifteen-minute habituation period in a clean cage and the 
repetitive behaviors of grooming, rearing, climbing, and digging were observed 
and scored by hand for fifteen minutes. The researchers were blind to the identity 
of each mouse prior to data analysis. The two groups, exposed and control mice, 
were averaged and the groups compared with a t-test.  
1.2.1.6 Elevated Zero Maze Test  
 The elevated zero maze behavioral test was performed to test for 
anxiolytic behaviors that could have affected the outcome of other behavioral 
tests. An elevated zero apparatus was used from Maze Engineers (Boston, MA). 
The mice were placed at one of the four points where the raised edges meet the 
open maze, chosen at random. Their behavior was observed for 5 minutes after 
being placed onto the maze. Noldus ethovision was used to record and score the 
test. The time spent in open vs closed arms was scored and compared using a t-
test. 
1.2.2 Microelectrode Fabrication  
Carbon fiber microelectrodes (CFMs) were made in house by aspirating 
carbon fibers into glass capillaries and pulled to a tight seal with a glass pipette 
puller. Exposed carbon fibers were cut to 150 micrometers for serotonin 




with silver colloidal paint into the glass capillary. Finally, a thin layer of Nafion 
was electropolymerized onto the carbon surface and cured in a 70 ⁰C oven for 10 
minutes prior to use in vivo. This process has been extensively described by 
Hashemi et al. 24.  
1.2.3 Animal Surgeries 
All animal procedures were performed in agreement with IACUC 
guidelines at the University of South Carolina, accredited by AAALAC. Male and 
female C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME, USA) aged 7-12 
weeks and weighing between 17.0 – 30.0 grams were used. Mice were chosen 
at random, with no regard for the female estrous cycle, and injected with a 25% 
w/v solution of urethane intraperitoneally to induce and maintain anesthesia. 
Body temperature was maintained at 37 ⁰C with a heating pad (BrainTree 
Scientific). Stereotaxic coordinates for the mPFC were taken in reference to 
bregma. A Nafion-coated CFM was lowered into the mPFC (+1.70 AP, -0.20 ML, 
-2.00 DV) for serotonin measurements. A stainless-steel stimulation electrode 
(SE) was lowered into the medial forebrain bundle (MFB) (-1.58 AP, -1.00 ML, -
4.80 DV). A pseudo Ag/AgCl reference electrode, made by electroplating AgCl 
onto a Ag wire, was placed in a contralateral hemisphere.  
1.2.4 Fast-scan Cyclic Voltammetry (FSCV) 
The serotonin waveform is generated by a PCIe-6341 DAC/ACD card 
(National Instruments) and scanned at 1000 Vs-1 from 0.2 V to 1.0 V to -0.1 V 
and back to the resting potential of 0.2 V at a frequency of 10 Hz using a 




the working electrode will be moved in the dorsal-ventral plane until a classic 
serotonin signal is found in the mPFC. A minimum of four control files are taken 
prior to any pharmaceutical or toxin exposure to observe the baseline of evoked 
serotonin for each animal. An acute dose of lead acetate (Sigma Aldrich) was 
given to a cohort of healthy, unexposed mice at a dose of 1.5, 15, or 150 ppb 
Pb2+. Acute effects of Pb2+ on the serotonin system were observed at 10-minute 
increments for 60 minutes. A cohort of mice chronically exposed to 15 ppb of 
Pb2+ acetate in their drinking water was given 10 mg/kg of escitalopram (ESCIT) 
after control files were taken and the effect of the SSRI was observed for 60 
minutes at 10-minute increments.  
1.2.5  Histology 
 After the surgery is complete, a large voltage of approximately 13 V is 
applied to the working electrode in vivo causing it to break and form a lesion where 
serotonin measurements were taken. The lesion allows for visualization of the 
electrode location during histology. The mouse was euthanized by cervical 
dislocation followed by decapitation, in accordance with IACUC, and the brain 
was harvested. The harvested brain was stored in paraformaldehyde (PFA) at 0 
⁰C for a minimum of three days. At least 24 hours prior to slicing the brain, it was 
transferred to a 30% w/w sucrose solution (Sigma Aldrich) to fill in the capillaries. 
A cryotome was used to maintain the tissue between -20 ⁰C and -25 ⁰C while 
slicing 30 micrometer thick slices. The slices with the brain regions of interest 




examination under microscopes to determine the exact placement of the working 
and stimulation electrodes.   
1.3 Results   
1.3.1 Acute Exposure to Lead 
The baseline responses of evoked serotonin in the mPFC of healthy, mature 
mice were recorded and then given bolus injections of Pb2+ at 1.5, 15, and 150 
ppb. The effects of these acute exposures on serotonin neurochemistry were 
observed for 60 minutes post-injection. Since FSCV signals in the mPFC vary 
with electrode placement, results were grouped as single and double peak 










1.3.2 Evoked Serotonin in the mPFC layers 1-3  
 
Figure 1.2 Response to an Acute Dose of Pb2+ in Layers 1-3 of the mPFC: 
Evoked serotonin (stimulation represented by the gray bars) release prior to and 
after acute doses of Pb2+ at 1.5, 15, and 150 ppb in layers 1-3 of the mPFC. 
Each animal was given a bolus of Pb2+ after four control files were collected. Row 
A shows the evoked 5-HT concentration (nM) vs. time plots of each dose. The 
faded colors of each trace represent the standard error of the mean (SEM), and 
the sample sizes are below each curve. Row D shows the maximum amplitude 
reached by the traces in Row A. Here, the largest points are the averages of the 
animals and the smaller points the individual animals themselves.  The largest 
points are the averages of each animal, represented by the smaller points. 
Columns A, B, and C represent the responses to 1.5, 15, and 150 ppb Pb2+, 
respectively.  
 
 In layers 1-3 of the mPFC, the acute exposure of 1.5 ppb Pb2+ caused 
evoked 5-HT to slightly decrease after 30 minutes, but almost recover to the 
control level, figure 2 column A. A decrease in amplitude was also observed after 
exposure to 15 ppb Pb2+ without recovering to control levels, figure 2 column B. 
These changes in amplitude are not significantly different (p=0.24 and 0.35, 




150 ppb Pb2+ and persisted after 60 minutes (p=0.03), shown in figure 2 column 
C.  
Changes in reuptake are quantitatively represented by the time (s) it took each 
curve to decay by one-half (t1/2). There were no significant changes in reuptake 
mechanisms for any of the dose responses, outlined in table 1, although slightly 
slower reuptakes were consistent across all doses after 30 and 60 minutes.  
Table 1.1 shows the time (s) it took each reuptake curve in figure 2, row A to 
decay by one-half (t1/2) with their respective SEM, with significance conducted via 
a t-test.  
 
 
1.3.3 Evoked Serotonin in the mPFC layers 5-6 
 
 
Figure 1.3 Response to an Acute Dose of Pb2+ in Layers 5-6 of the mPFC: 
Evoked 5-HT signals (stimulation represented by the gray bar) in response to an 
acute dose of either 1.5, 15, or 150 ppb Pb2+ in the mPFC layers 5-6. Each 
animal was given a bolus of Pb2+ after four control signals were collected. The 
concentration (nM) vs. time (s) curves are the average of several animals, 
denoted at the bottom of each curve, with the faded colors representing the SEM. 





When the working electrode was placed in layers 5-6 of the mPFC, the 
response to an acute dose of Pb2+ was slightly different than when placed in 
layers 1-3. As previously mentioned, there are two different projections of 
serotonin neurons in the mPFC that are layer-specific, resulting in two distinct 
peaks. Shown in figure 3, the amplitude of evoked serotonin for both peaks 
slightly decreased after acute doses of 1.5 and 150 ppb Pb2+, but the decreases 
were not statistically significant (p= 0.29 and 0.09 ,respectively). There was no 
change in the amplitude of the first peak, but a slight increase over 60 minutes 
was observed in the second peak of the 15 ppb Pb2+ dose response, but this was 
also not statistically significant (p= 0.81).  
Changes in reuptake mechanisms for each peak were calculated via a t1/2 
value. For each of the first peaks in figure 3, no changes in reuptake were 
observed. After doses of 1.5 and 15 ppb Pb2+, there were slight delays in 
reuptake via the SERTs, but not statistically significant (p= and , respectively). No 
significant change in the second reuptake for the 150 ppb Pb2+ dose was 
observed.  
1.3.4 Chronic Exposure to Lead 
Mice were exposed to 15 ppb Pb2+ in their drinking water for one week while 
control mice received lead-free drinking water from the Animal Care Center. The 
evoked serotonin signals are shown in figure 3. The chronic mice had a slightly 
lower maximum amplitude than the control mice, but this was not significantly 
different with p=0.5, determined by a t-test. The reuptake of 5-HT by the 




(t1/2). The t1/2 values for the control and exposed mice were 9.6 and 9.8 s, 
respectively. These values were determined to not be significantly different 
(p=0.7) via a t-test. It is important to note that the evoked serotonin signals for the 
exposed mice were acquired after exposure, and the control signals for each 
animal prior to exposure could not be acquired.  
 
Figure 1.4 Response to a Chronic Exposure to Pb2+: Chronic 1-
week exposure to 15 ppb Pb2+ in drinking water. The stimulated 
release of serotonin (stimulation denoted by the gray bar) in control 
and chronically exposed animals. Control animals are shown in green 
(n=6), and chronic exposure animals are shown in blue (n=6). There 
was no significant difference between the maximum amplitudes 
(p=0.5) nor the reuptake (p=0.7) of 5-HT.  
 
1.3.5 Perinatal Exposure to Lead  
At 8 weeks of age, mice that were peritoneally exposed to 15 ppb Pb2+ were 
administered behavioral tests to determine whether the exposure caused 




children, shown in figure 5. No significant behavioral changes were observed 
between the control and exposed mice. Although, the exposed mice climbed 
significantly less than the controls, determined by a t-test (p=0.002). 
 
 
Figure 1.5 Behavioral Tests After a Perinatal Exposure to Pb2+: Behavioral 
test results between control mice (blue, n=18) and those perinatally exposed to 
15 ppb Pb2+ (yellow, n=22). A depicts the Crawley Three-Chamber Social test for 
social deficits. B shows the elevated zero maze test for anxiolytic behaviors. C 
shows the results of the marble burying test, for repetitive, compulsive behaviors. 
D depicts the results of the Olfactory Habituation/Dishabituation test with five 
scents to determine social deficits. E shows the repetitive behaviors observed in 
the open field test. A t-test determined that the only statistically significant 
change in behavior was repetitive climbing (p=0.002), denoted by a black star.   
 
After behavioral testing was done, FSCV was performed to observe any 
changes in serotonin neurochemistry, shown in figure 6. Slightly higher 
amplitudes of evoked 5-HT were observed in the exposed mice, although this 




reuptake mechanisms were observed between the two groups, quantified by the 
t1/2 values for each curve’s decay (p=0.1).  
 
Figure 1.6 Response to a Perinatal Exposure to Pb2+: Evoked 
serotonin (stimulation denoted by the gray bar) of both control mice  
(black, n=7) and those perinatally exposed to 15 ppb Pb2+ (gold, n=7).  
 
1.4 Discussion 
1.4.1 Functional Disruptions of Autoreceptors and Transporters by Pb2+  
The acute dose of 150 ppb Pb2+ caused significant decreases in the 
amplitude of evoked 5-HT, without altering reuptake mechanisms of the 
transporters. All other doses caused decreases in amplitude, albeit insignificant, 
also without altering reuptake. Disruptions in reuptake are caused by 
malfunctioning transporters, but since reuptake was not altered, the transporters 




Alternatively, the consistent decrease in evoked serotonin after acute Pb2+ 
exposure implicates the autoreceptors and Ca2+ competition as the cause of 
dampening serotonin levels. Pb2+ has an affinity to bind to G-coupled protein 
receptors (GPCRs), which are the type of receptor the 5-HT2A autoreceptors are 
in the mPFC21. 5-HT2A autoreceptors are abundantly expressed in the mPFC, 
therefore Pb2+ could be binding and falsely signaling excessive 5-HT in the 
synapse, causing the neurons to cease firing. Pb2+ also readily competes with 
and mimics Ca2+ function during action potentials, causing an increased or 
decreased release of 5-HT into the synapse, depending upon the mechanism of 
disruption by Pb2+9. This could add to the fact that serotonin isn’t dampened 
significantly, because firing is varied, causing some animals to have slight 
increases or significant increases in evoked serotonin levels.  
1.4.2 Inflammation caused by Pb2+ exposure  
Pb2+ has been extensively shown to induce neuroinflammation, therefore, 
indirectly altering serotonin neurochemistry20. The administration of Pb2+ in brain 
slices causes glial activation, a hallmark of a neuroinflammatory response. Each 
animal has their own inflammatory response to Pb2+ exposure, which could 
explain a lack of statistical significance in the evoked serotonin decreases after 
acute Pb2+ exposure.  
Our lab has previously shown that evoked serotonin proportionally decreases 
with increased levels of histamine after pharmacological induction of 
neuroinflammation, implicating the H3 receptor in the tight regulation of 




neuroinflammation, this could explain the dampening of evoked serotonin after 
an acute dose of Pb2+. It seems that the brain was able to return to serotonergic 
homeostasis at the lowest doses, but not at the highest, alluding to an 
inflammatory response that is both animal and dose dependent.  
1.4.3 Chronic and Perinatal Exposure of Pb2+   
No statistically significant alterations in the evoked release nor reuptake of 
serotonin were found in either the chronic and perinatal cohorts. With this method 
of exposure, a limitation becomes apparent in the voltammetry. Each animal has 
their own baseline of evoked serotonin, but this cannot be determined prior to 
Pb2+ exposure. Additionally, the location of the electrode cannot be precisely 
replicated in each animal, therefore a control level could not be determined. No 
drastic difference was observed between the exposed and control animals, but 
the levels of evoked serotonin were comparable, so the conclusion can be drawn 
that there were no alterations to serotonin neurotransmission.  
Based on the results of the acute exposure paradigm, we expected the long-
term exposure to cause more dramatic alterations in serotonin neurochemistry. 
However, this is logically explained by the body’s tight regulation of serotonin 
neurochemistry, resulting in a compensation to maintain homeostasis after being 
exposed to a toxin over a long period of time. Additionally, the dose of 15 ppb 
Pb2+ was much lower than previously reported studies that caused behavioral 
changes, therefore the body’s compensation mechanisms were able to overcome 




term exposure of 15 ppb Pb2+ is not enough to cause significant behavioral and 
neurochemical changes in mature mice.  
1.5 Conclusion  
The administration of an acute dose of Pb2+ caused evoked serotonin signals 
to decrease in the mPFC of mature mice, but not all doses caused significant 
decreases. This could be due to two known mechanisms of Pb2+ in the brain: 
binding to serotonin autoreceptors and competing or mimicking Ca2+. The lack of 
statistical significance could also be attributed to Pb2+ being able to increase or 
decrease serotonin signaling, resulting in variable responses by each animal. 
Overall, low doses of Pb2+ can be quickly recovered from by the body as shown 
by the recovery to control levels in the 1.5 ppb dose.  
Although no statistical significance was observed between control animals 
and those exposed to Pb2+ chronically and perinatally, this highlights a limitation 
with FSCV. A baseline of evoked serotonin for each animal is imperative to 
determine the effects of exposure to a toxin. As the animals in this study were 
exposed to Pb2+ prior to voltammetric measurements, the baseline was not able 
to be determined. These results could also indicate that chronic exposure low 
enough doses of Pb2+ does not significantly impact serotonin neurochemistry. 
Chronic exposures to higher doses of Pb2+ for longer periods of time could be 
useful to determine a minimum time frame and dose that will definitively cause 
long-term damage.  
The serotonergic system seems to be well-defended against the effects of 




water for several months, like those in Washington D.C. and Flint, Michigan, the 
long-term effects of exposure could be significantly disrupting other signaling 
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